Thoratec's HeartMate II gets US nod for bridge-to-transplantation
This article was originally published in Clinica
Executive Summary
The HeartMate II left ventricular assist system (LVAS) developed by Thoratec has been approved in the US as a bridge-to-transplantation (BTT) device in patients with advanced heart failure. It is the first continuous flow device to receive FDA approval for this indication.